Sunday share tips: Journey Group, GW Pharmaceuticals, Inland Homes

23rd Mar 2014 16:57

Journey Group should benefit from the economic recovery and the knock-on effect on airlines, Midas said in the Mail on Sunday. The company, which is based in the UK but serves Los Angeles airport only, provides high quality airline food made at top restaurants during their quiet periods and transported to planes using a patented chilling method. Its results on March 25th are expected to show a 25% rise in profits to £1.8m for 2013. There is plenty of room for expansion and investors should "buy now".GW Pharmaceuticals is now taken seriously after early dismissal of its strategy of developing medicines made from cannabis, the Sunday Times's Inside the City column said. It raised money for expansion last year in the US and gained a secondary listing on Nasdaq. The company's share price has soared in the past year and much of the rise is based on hopes for its children's epilepsy treatment Epidiolex. Unlike its earlier drug for multiple sclerosis, Savitex, GW retains all the commercial rights in Epidiolex and the new treatment shows it is not a one-trick pony. UK investors are rediscovering biotech shares.Existing shareholders in Inland Homes should hold on to their stakes and new investors could still get value at current levels, the Mail on Sunday's Midas column said in an update. The shares have surged 48% since Midas tipped them in August. The company specialises in buying brownfield sites for development as housing. The extension of the government's Help to Buy scheme should be good for and, despite the shares' gains, Inland is still relatively cheap compared with its peers.Tui Travel and rival tour operator Thomas Cook report on trading on March 26th and 27th respectively. The Sunday Times's Inside the City column said both should report positive news because recent wet weather will have sent people looking for sun. SFPlease note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.